Clinical trial
Immunogenicity of the Booster Dose of Two MenC Vaccines
NCT00392808 · Centro Superior de Investigación en Salud Publica, Other · Completed
Key facts
| NCT number | NCT00392808 |
|---|---|
| Title | Immunogenicity of the Booster Dose of Two MenC Vaccines |
| Official title | Randomized, Open Label, Active Control, Parallel Assignment Clinical Trial to Evaluate the Immunogenicity of Polysaccharide Meningococcal C Vaccines Conjugated With Tetanus Toxoid or CRM197 Given as a Booster Dose at 14-18 Months of Life. |
| Acronym | CSISP-MENC1 |
| Lead sponsor | Centro Superior de Investigación en Salud Publica, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Meningococcal Infection |
| Intervention type | Biological |
| Interventions | conjugated polysaccharide menC vaccine |
| Enrollment | 389 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Oct 26, 2006 |
| Last update posted | Oct 11, 2013 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: